Recurrent B Acute Lymphoblastic Leukemia: Clinical Trials

1 trial for Recurrent B Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Recurrent B Acute Lymphoblastic Leukemia: new trials by email Literature Review of Recurrent B Acute Lymphoblastic Leukemia trials Research Report on Recurrent B Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase, Blinatumomab - Recurrent B Acute Lymphoblastic Leukemia
Phase 3Active not recruitingNational Cancer Institute (NCI)6692014-12-172026-11-18

Narrower conditions

Burkitt Lymphoma (1)

Broader conditions

DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Tumor Virus Infections (1)

Interventions

Asparaginase (1)  ·  Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Dexamethasone (1)  ·  Etoposide (1)  ·  Hydrocortisone (1)  ·  Leucovorin (1)  ·  Leyk (1)  ·  Mercaptopurine (1)  ·  Methotrexate (1)  ·  Mitoxantrone (1)  ·  N,N-dicyclohexyl-isoborneol-10-sulfonamide (1)  ·  Radiation (1)  ·  Radiotherapy (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Patrick A Brown (1)

Results publications

PMID 33651090, PMID 37257143, PMID 40568722

NIH funding

U10CA098543 (1), U10CA180886 (1)